Cargando…

Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteria

Significant morphological, clinical and biological prognostic factors vary according to molecular subtypes of breast tumors, yet comprehensive analysis of such factors linked to survival in each group is lacking. Clinicopathological and micro-environmental criteria, estrogen (ER), progesterone (PR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Mascarel, Isabelle, Debled, Marc, Brouste, Véronique, Mauriac, Louis, Sierankowski, Ghislaine, Velasco, Valérie, Croce, Sabrina, Chibon, Frédéric, Boudeau, Jêrome, Debant, Anne, MacGrogan, Gaëtan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576021/ https://www.ncbi.nlm.nih.gov/pubmed/26405647 http://dx.doi.org/10.1186/s40064-015-1297-8

Ejemplares similares

Epithelial atypia in biopsies performed for microcalcifications. Practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up
por: de Mascarel, Isabelle, et al.
Publicado: (2007)

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer
por: Bellera, Carine A, et al.
Publicado: (2010)

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.
por: MacGrogan, G., et al.
Publicado: (1996)

Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients
por: de Mascarel, I, et al.
Publicado: (2002)

MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors
por: Pérot, Gaëlle, et al.
Publicado: (2012)

An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis
por: Bonnet, Françoise, et al.
Publicado: (2012)

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer
por: MacGrogan, G, et al.
Publicado: (2003)

Separate and combined analysis of successive dependent outcomes after breast-conservation surgery: recurrence, metastases, second cancer and death
por: Rondeau, Virginie, et al.
Publicado: (2010)

An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
por: Blaye, C., et al.
Publicado: (2022)

Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers
por: Puccetti, Paolo, et al.
Publicado: (2015)

Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations
por: Banneau, Guillaume, et al.
Publicado: (2010)

Prognostic Value of PLAGL1-Specific CpG Site Methylation in Soft-Tissue Sarcomas
por: Peille, Anne-Lise, et al.
Publicado: (2013)

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer
por: Quenel-Tueux, Nathalie, et al.
Publicado: (2015)

Humanization of the mouse mammary gland by replacement of the luminal layer with genetically-engineered preneoplastic human cells
por: Verbeke, Stephanie, et al.
Publicado: (2014)

Erratum to: Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells
por: Verbeke, Stephanie, et al.
Publicado: (2015)

Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis
por: Debled, M, et al.
Publicado: (2007)

The +TIP Navigator-1 is an actin–microtubule crosslinker that regulates axonal growth cone motility
por: Sánchez-Huertas, Carlos, et al.
Publicado: (2020)

Group-I PAKs-mediated phosphorylation of HACE1 at serine 385 regulates its oligomerization state and Rac1 ubiquitination
por: Acosta, Maria I., et al.
Publicado: (2018)

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
por: Vincent-Salomon, Anne, et al.
Publicado: (2007)

Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases
por: Morgat, Clément, et al.
Publicado: (2019)

Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials
por: Lerebours, Florence, et al.
Publicado: (2020)

Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist (68)Ga-RM2 and (18)F-FDG in breast cancer samples
por: Morgat, Clément, et al.
Publicado: (2019)

Validation of death prediction after breast cancer relapses using joint models
por: Mauguen, Audrey, et al.
Publicado: (2015)

Terahertz refractive index-based morphological dilation for breast carcinoma delineation
por: Cassar, Quentin, et al.
Publicado: (2021)

The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study
por: Tunon-de-Lara, Christine, et al.
Publicado: (2015)

Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre
por: Linck, Pierre-Antoine, et al.
Publicado: (2021)

Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations
por: Rouault, Audrey, et al.
Publicado: (2012)

Event display and CDF and D0
por: Boudeau, J
Publicado: (1997)

Experiences with Open Inventor
por: Boudeau, J
Publicado: (1997)

Self-harm injury hospitalisations: an analysis of case selection criteria
por: Imm, Pamela, et al.
Publicado: (2021)

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes
por: Bonnefoi, Hervé, et al.
Publicado: (2019)

Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma
por: Mairé, Mathilde, et al.
Publicado: (2022)

Adult desmoid tumors: biology, management and ongoing trials
por: Penel, Nicolas, et al.
Publicado: (2017)

Greatwall promotes cell transformation by hyperactivating AKT in human malignancies
por: Vera, Jorge, et al.
Publicado: (2015)

Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers
por: Miolo, GianMaria, et al.
Publicado: (2009)

Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value
por: Shaker, Nada, et al.
Publicado: (2022)

Immunohistochemical evidence of Muc1 expression during rat embryonic development
por: Lacunza, E., et al.
Publicado: (2010)

Acquisition of cancer stem cell capacities after spontaneous cell fusion
por: Merle, Candice, et al.
Publicado: (2021)

Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases
por: Vecchione, Andrea, et al.
Publicado: (2004)

Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development
por: Grego-Bessa, Joaquim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5bj3ui89dijegvn2io9k91borm